The nuclear eicosanoid receptor, PPARγ, is aberrantly expressed in colonic cancers

Carcinogenesis

Volumn 19, Issue 1, 1998, Pages 49-53

  DuBois, Raymond N ^a,b   Gupta, Rajnish ^b   Brockman, Jeffrey ^a   Reddy, Bandaru S ^c   Krakow, Samuel L ^d   Lazar, Mitchell A ^d  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c AMERICAN HEALTH FOUNDATION   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ICOSANOID; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PROSTAGLANDIN J2; TRANSCRIPTION FACTOR;

ARTICLE; CANCER CELL CULTURE; CELL STRAIN CACO 2; COLON CANCER; COLON MUCOSA; COLON POLYP; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; TRANSACTIVATION;

ADENOCARCINOMA; ANIMALS; AZOXYMETHANE; CARCINOGENS; COLONIC NEOPLASMS; EICOSANOIDS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; NUCLEAR PROTEINS; PROTEIN BIOSYNTHESIS; RATS; RATS, INBRED F344; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECOMBINANT PROTEINS; RNA, MESSENGER; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0031844535     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/19.1.49     Document Type: Article

References (45)

1. Giovannucci, E., Egan, K.M., Hunter, D.J., Stampfer, M.J., Colditz, G.A., Willett, W.C. and Speizer, F.E. (1995) Aspirin and the risk of colorectal cancer in women. N. Eng. J. Med., 333, 609-614.
2. Greenberg, E.R., Baron, J.A., Freeman, D.H.J., Mandel, J.S. and Haile, R. (1993) Reduced risk of large-bowel adenomas among aspirin users. The Polyp Prevention Study Group. J. Natl Cancer. Inst., 85, 912-916.
3. Thun, M.J., Namboodiri, M.M. and Heath, C.W.J. (1991) Aspirin use and reduced risk of fatal colon cancer. N. Engl. J. Med., 325, 1593-1596.
4. Thun, M.J., Namboodiri, M.M., Calle, E.E., Randers, W.D. and Heath, C.W.J. (1993) Aspirin use and risk of fatal cancer. Cancer Res., 53, 1322-1327.
5. Peleg, I.I., Maibach, H.T., Brown, S.H. and Wilcox, C.M. (1994) Aspirin and nonsteroidal anti-inflammatory drug use and the risk of subsequent colorectal cancer. Arch. Int. Med., 154, 394-9.
6. Giovannucci, E., Rimm, E.B., Stampfer, M.J., Colditz, G.A., Ascherio, A. and Willett, W.C. (1994) Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann. Intern. Med., 121, 241-246.
7. Giardiello, F.M., Hamilton, S.R., Krush, A.J., Piantadosi, S., Hylind, L.M., Celano, P., Booker, S.V., Robinson, C.R. and Offerhaus, G.J. (1993) Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N. Engl. J. Med., 328, 1313-1316.
8. Waddell, W.R. and Loughry, R.W. (1983) Sulindac for polyposis of the colon. J. Surg. Oncol., 24, 83-87.
9. Waddell, W.R., Gasner, G.F., Cerise, E.J. and Loughry, R.W. (1989) Sulindac for polyposis of the colon. Am. J. Surg., 157, 175-178.
10. Winde, G., Gumbinger, H.G., Osswald, H., Kemper, F. and Bunte, H. (1993) The NSAID sulindac reverses rectal adenomas in colectomized patients with familial adenomatous polyposis: clinical results of a dose-finding study on rectal sulindac administration. Int. J. Colorectal. Dis., 8, 13-17.
11. Nugent, K.P., Farmer, K.C., Spigelman, A.D., Williams, C.B. and Phillips, R.K. (1993) Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis. Brit. J. Surg., 80, 1618-1619.
12. Reddy, B.S., Nayini, J., Tokumo, K., Rigotty, J., Zang, E. and Kelloff, G. (1990) Chemoprevention of colon carcinogenesis by concurrent administration of piroxicam, a nonsteroidal antiinflammatory drug with D,L-alpha-difluoromethylomithine, an ornithine decarboxylase inhibitor, in diet. Cancer Res., 50, 2562-2568.
13. Reddy, B.S., Rao, C.V. Rivenson, A. and Kelloff, G. (1993) Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in F344 rats. Carcinogenesis, 14, 1493-1497.
14. Craven, P.A. and DeRubertis, F.R. (1992) Effects of aspirin on 1,2-dimethylhydrazine-induced colonic carcinogenesis. Carcinogenesis, 13, 541-546.
15. Reddy, B.S., Rao, C.V. and Seibert, K. (1996) Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis. Cancer Res., 56, 4566-4569.
16. Eberhart, C.E., Coffey, R.J., Radhika, A., Giardiello, F.M., Ferrenbach, S. and DuBois, R.N. (1994) Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology, 107, 1183-1188.
17. Kargman, S., O'Neill, G., Vickers, P., Evans, J., Mancini, J. and Jothy, S. (1995) Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. Cancer Res., 55, 2556-2559.
18. Sano, H., Kawahito, Y., Wilder, R.L., Hashiramoto, A., Mukai, S., Asai, K., Kimura, S., Kato, H., Kondo, M. and Hla, T. (1995) Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res., 55, 3785-3789.
19. Kutchera, W., Jones, D.A., Matsunami, N., Groden, J., McIntyre, T.M., Zimmerman, G.A., White, R.L. and Prescott, S.M. (1996) Prostaglandin H synthase-2 is expressed abnormally in human colon cancer: Evidence for a transcriptional effect. Proc. Natl Acad. Sci. USA, 93, 4816-4820.
20. DuBois, R.N., Radhika, A., Reddy, B.S. and Entingh, A.J. (1996) Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors. Gastroenterology, 110, 1259-1262.
21. Williams, C.W., Luongo, C., Radhika, A., Zhang, T., Lamps, L.W., Nanney, L.B., Beauchamp, R.D. and DuBois, R.N. (1996) Elevated cyclooxygenase-2 levels in Min mouse adenomas. Gastroenterology, 111, 1134-1140.
22. Δ716 knockout mice by inhibition of prostaglandin endoperoxide synthase-2 (COX-2). Cell, 87, 803-809.
23. Prescott, S.M. and White, R.L. (1996) Self promotion? Intimate connections between APC and prostaglandin H synthase-2. Cell, 87, 783-786.
24. Sheng, H., Shao, J., Kirkland, S.C., Isakson, P., Coffey, R., Morrow, J., Beauchamp, R.D. and DuBois, R.N. (1997) Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. J. Clin. Invest., 99, 2254-2259.
25. Williams, C.S., Smalley, W. and DuBois, R.N. (1997) Aspirin use and potential mechanisms for colorectal cancer prevention. J. Clin. Invest., 100, 1-5.
26. Yu, K., Bayona, W., Kallen, C.B., Harding, H.P., Ravera, C.P., McMahon, G., Brown, M. and Lazar, M.A. (1995) Differential activation of peroxisome proliferator-activated receptors by eicosanoids. J. Biol. Chem., 270, 23975-23983.
27. Forman, B.M., Tontonoz, P., Chen, J., Brun, R.P., Spiegelman, B.M. and Evans, R.M. (1995) 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR. Cell, 83, 803-812.
28. Kliewer, S.A., Lenhard, J.M., Willson, T.M., Patel, I., Morris, D.C. and Lehmann, J.M. (1995) A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation. Cell, 83, 813-819.
29. Chawla, A., Schwarz, E.J., Dimaculangan, D.D. and Lazar, M.A (1994) Peroxisome proliferator-activated receptor (PPAR) gamma: adipose-predominant expression and induction early in adipocyte differentiation. Endocrinology, 135, 798-800.
30. Tontonoz, P., Hu, E., Graves, R.A., Budavari, A.I. and Spiegelman, B.M. (1994) mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer. Genes Dev., 8, 1224-1234.
31. Rao, C.V., Tokumo, K., Rigotty, J., Zang, E., Kelloff, G. and Reddy, B.S. (1991) Chemoprevention of colon carcinogenesis by dietary administration of piroxicam, alpha-difluoromethylornithine, 16 alpha-fluoro-5-androsten-17-one, and ellagic acid individually and in combination. Cancer Res., 51, 4528-4534.
32. DuBois, R.N., Tsujii, M., Bishop, P., Awad, J.A., Makita, K. and Lanahan, A. (1994) Cloning and characterization of a growth factor-inducible cyclooxygenase gene from rat intestinal epithelial cells. Am. J. Physiol., 266, G822-G827.
33. DuBois, R.N., Awad, J., Morrow, J., Roberts, L.J. and Bishop, P.R. (1994) Regulation of eicosanoid production and mitogenesis in rat intestinal epithelial cells by transforming growth factor-α and phorbol ester. J. Clin. Invest., 93, 493-498.
34. Xue, J.C., Schwartz, E.J., Chawla, A. and Lazar, M.A. (1996) Distinct stages in adipogenesis revealed by retinoid inhibition of differentiation after induction of PPARgamma. Mol. Cell. Biol., 16, 1567-1575.
35. Michael, L.F., Lazar, M.A. and Mendelson, C.R. (1997) PPAR gamma1 expression is induced during cyclic AMP-stimulated differentiation of alveolar type II pneumocytes. Endocrinology, 138, 3695-3703.
36. Vidal-Puig, A., Jimenez-Linan, M., Lowell, B.B., Hamann, A., Hu, E., Spiegelman, B., Flier, J.S. and Moller, D.E. (1996) Regulation of PPAR gamma gene expression by nutrition and obesity in rodents. J. Clin. Invest., 97, 2553-2561.
37. Vidal-Puig, A.J., Considine, R.V., Jimenez-Linan, M., Werman, A., Pories, W.J., Caro, J.F. and Flier, J.S. (1997) Peroxisome proliferator-activated receptor gene expression in human tissues: effects of obesity, weight loss, and regulation by insulin and glucocorticoids. J. Clin. Invest., 99, 2416-2422.
38. Kinzler, K.W. and Vogelstein, B. (1996) Lessons from hereditary colorectal cancer. Cell, 87, 159-170.
39. Camp, H.S. and Tafuri, S.R. (1997) Regulation of peroxisome proliferator-activated receptor γ activity by mitogen-activated protein kinase. J. Biol. Chem., 272, 13452-13457.
40. Adams, M., Reginato, M.J., Shao, D., Lazar, M.A. and Chatterjee, V.K. (1997) Transcriptional activation by peroxisome proliferator-activated receptor gamma is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site. J. Biol Chem., 272, 5128-5132.
41. Hu, E., Kim, J.B., Sarraf, P. and Spiegelman, B.M. (1996) Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma. Science, 274, 2100-2103.
42. Zhang, B., Berger, J., Zhou, G., Elbrecht, A., Biswas, S., White-Carrington, S., Szalkowski, D. and Moller, D.E. (1996) Insulin-and mitogen-activated protein kinase-mediated phosphorylation and activation of peroxisome proliferator-activated receptor gamma. J. Biol. Chem., 271, 31771-31774.
43. Smalley, W. and DuBois, R.N. (1997) Colorectal cancer and non steroidal anti-inflammatory drugs. Adv. Pharmacol., 39, 1-20.
44. Watson, A.J.M. and DuBois, R.N. (1997) Lipid metabolism and APC-Implications for colorectal cancer prevention. Lancet, 349, 444-445.
45. Tsujii, M., Kuwano, S. and DuBois, R.N. (1997) Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc. Natl Acad. Sci. USA, 94, 3336-3340.